Koninklijke Philips | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 40.03B 468M 2024-12
Baxter International USD 6.96B 908M 2024-12
Becton, Dickinson and Co. USD 25.2B 685M 2024-12
Boston Scientific USD 21.77B 1.06B 2024-12
Danaher USD 49.54B 1.76B 2024-12
Demant DKK 9.56B 42M 2024-12
Dexcom USD 2.1B 123.6M 2024-12
Edwards Lifesciences USD 10B 452.8M 2024-12
Fresenius EUR 19.54B 715M 2024-12
General Electric USD 19.57B 691M 2024-12
Getinge SEK 33.01B 2.75B 2024-12
Globus Medical USD 4.18B 107.94M 2024-12
GN Store Nord DKK 10.82B 637M 2024-12
Hitachi JPY 5.85T 347.42B 2024-12
Hologic USD 4.77B 356.7M 2024-12
Idexx Laboratories USD 1.6B 22.74M 2024-12
Insulet USD 1.21B 93.6M 2024-12
Integra LifeSciences USD 1.55B 23.69M 2024-12
Intuitive Surgical USD 16.53B 946.3M 2024-12
J&J USD 71.49B 1.33B 2024-12
Koninklijke Philips EUR 12.01B 569M 2024-12
Masimo USD 1.05B 411.3M 2024-12
Medtronic USD 49.39B 893M 2025-01
Philips EUR 12.01B 87M 2024-12
ResMed USD 5.25B 57.98M 2024-12
Smith & Nephew USD 5.26B 60M 2024-12
Steris USD 6.43B 164.94M 2024-12
Stryker USD 20.63B 485M 2024-12
Teleflex USD 4.28B 203.58M 2024-12
Terumo JPY 1.4T 90.06B 2024-12
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Koninklijke Philips Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.